Eric Pauwels, CHIEF BUSINESS OFFICER at PTC THERAPEUTICS, INC. (PTCT), sold 21,277 shares at $75.00 ($1.6M) on 2026-06-10, disclosed to the SEC on 2026-06-12.
Scheduled sale ($1.6M) by CHIEF BUSINESS OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $75.00 | 3,711 | $278K | 17.4% |
| 2 | $75.00 | 17,566 | $1.3M | 82.6% |
| Total | $75.00 avg | 21,277 | $1.6M | 100% |
| Filing → |
| PTCT | SELL | 2026-01-08 | $242K | — | Filing → |
| PTCT | SELL | 2025-12-23 | $3.0M | — | Filing → |
| PTCT | SELL | 2025-12-19 | $6.5M | — | Filing → |